IIM
HUMA icon

INTECH Investment Management’s Humacyte HUMA Stock Holding History

INTECH Investment Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52,566
Closed -$31.9K – 2192
2026
Q1 		$31.9K Sell
52,566
-8,180
-13% -$8.5K ﹤0.01% 2044
2025
Q4 		$58.3K Sell
60,746
-60
-0.1% -$85 ﹤0.01% 2247
2025
Q3 		$106K Sell
60,806
-16,166
-21% -$31.7K ﹤0.01% 2241
2025
Q2 		$161K Sell
76,972
-13,200
-15% -$25.4K ﹤0.01% 2160
2025
Q1 		$154K Buy
90,172
+29,994
+50% +$113K ﹤0.01% 2182
2024
Q4 		$304K Buy
60,178
+17,563
+41% +$86.9K ﹤0.01% 1822
2024
Q3 		$232K Buy
+42,615
New +$281K ﹤0.01% 1653

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

INTECH Investment Management's HUMA Position: Q2 2026 in Review

INTECH Investment Management sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 52,566 shares — an estimated $31.9K sold.

INTECH Investment Management first reported a position in HUMA in Q3 2024 and held it in 7 quarters. The position peaked at $304K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • INTECH Investment Management reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 52,566 Humacyte shares in Q2 2026, an estimated $31.9K.
  • INTECH Investment Management first reported a position in Humacyte in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's Humacyte position peaked at $304K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.